Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.65 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.65 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.38 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.38 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.33 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.33 |
| ▸ | ACLY | P53396 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20830347 | 0.87 | OPRM1 (0.86) | OPRM1OPRD1NOD1NOD2ALDH1A1 | |
| SCHEMBL23483863 | 0.79 | OPRM1 (1.00) | OPRM1OPRD1NOD1NOD2ALDH1A1 | |
| SCHEMBL15413322 | 0.77 | OPRM1 (0.94) | OPRM1OPRD1NOD1NOD2ALDH1A1 | |
| SCHEMBL20816038 | 0.76 | OPRM1 (0.85) | OPRM1OPRD1NOD1NOD2ALDH1A1 | |
| SCHEMBL16486105 | 0.63 | NOD2 (0.58) | NOD1NOD2PTGS2ACLY | |
| SCHEMBL4190272 | 0.62 | NR4A2 (0.51) | OPRM1OPRD1NR4A2ALDH1A1TP53 | |
| SCHEMBL4190009 | 0.61 | MAPT (0.49) | ALDH1A1MAPTKDM4ESMN1; SMN2ATM | |
| SCHEMBL2775811 | 0.61 | OPRM1 (0.46) | OPRM1OPRD1NOD1NOD2ALDH1A1 | |
| SCHEMBL5250607 | 0.60 | PPARG (0.57) | NOD1NOD2ALDH1A1PTGS2KDM4E | |
| SCHEMBL6964954 | 0.59 | CCR2 (0.56) | NOD1NOD2PTGS2ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10577371-B2 | Small molecule histone methyltransferase SUV39H1 inhibitor and uses thereof | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2020-03-03 | — | — | US | claimed |
| US-20190084987-A1 | Small Molecule Histone Methyltransferase SUV39H1 Inhibitor and Uses Thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-03-21 | — | — | US | claimed |
| US-10577371-B2 | Small molecule histone methyltransferase SUV39H1 inhibitor and uses thereof | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2020-03-03 | — | — | US | disclosed |
| US-20190084987-A1 | Small Molecule Histone Methyltransferase SUV39H1 Inhibitor and Uses Thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10577371-B2 | Small molecule histone methyltransferase SUV39H1 inhibitor and uses thereof | SUV39H2, SUV39H1, EZH1 | OPRM1 4500/4885OPRD1 4790/4885NR4A2 3544/4885 |
| US-20190084987-A1 | Small Molecule Histone Methyltransferase SUV39H1 Inhibitor and Uses Thereof | SUV39H2, SUV39H1, EZH1 | OPRM1 4500/4885OPRD1 4790/4885NR4A2 3544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.